Socioeconomic and Clinical Profile of Diabetic Foot Ulcer Patients with National Health Insurance during Pandemic COVID-19 in Indonesia
Downloads
During the COVID-19 pandemic, the mandatory lockdown and government policy in prioritizing COVID-19 patients affected patients with diabetic foot ulcers (DFU). Most DFU patients experienced difficulties visiting hospitals and covering the cost of treatment, which led to changes in patient characteristics, poor clinical outcomes, and higher total costs. This study aimed to determine the sociodemographic and clinical outcomes profile of DFU patients under National Health Insurance (NHI-DFU) during the COVID-19 pandemic and their effect on the total direct medical cost. This cross-sectional study enrolled all JKN-DFU hospitalized patients at the National Referral Hospital, Cipto Mangunkusumo Hospital (RSCM), Jakarta, Indonesia, during COVID-19 pandemic (March 2nd, 2020, to December 2022). We used electronic health records, electronic billing, and foot registry systems. Participants were over 18 years old in a single admission period. Statistical analysis used Mann-Whitney and Kruskal-Wallis; Post hoc used the Mann-Whitney test. There were 158 JKN-DFU patients with predominated criteria: female patients (55.1%), aged over 60 years old (55.1%) with a mean age of 59.3 ± 11.0 years, unemployed (63.9%), intermediate educated (41.8%), Jakarta residents (68.4%), and mostly severe infection (63.3%). The total cost was much higher than INA-CBG’s coverage. The occupation (p=0.048), length of stay (LOS) (p=0.001), and amputation status (p<0.001) significantly affected total cost. Civil servants, longer LOS, and major amputation status leading higher total costs.
Downloads
Dardari D, Franc S, Charpentier G, Orlando L, Bobony E, Bouly M, et al. Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study. Lancet Regional Health – Europe, The. 2023;32(September):1–11. DOI: 10.1016/j.lanepe.2023.100686
van Netten JJ, Bus SA, Apelqvist J, Chen P, Chuter V, Fitridge R, et al. Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2023;(April):1–6. DOI: 10.4103/jfmpc.jfmpc_257_19
Monteiro-Soares M, Vale-Lima J, Martiniano J, Pinheiro-Torres S, Dias V, Boyko EJ. A systematic review with meta-analysis of the impact of access and quality of diabetic foot care delivery in preventing lower extremity amputation. Journal Diabetes Complications. 2021;35(4). DOI: 10.1016/j.jdiacomp.2020.107837
International Diabetes Federation. IDF Diabetes Atlas 2021. 10th Edition. Boyko, Edward J; Magliano, Dianna J; Karuranga, Suvi; Piemonte,, Lorenzo; Saeedi PRPHS, editor. Vol. 10. Brussels, Belgium: International Diabetes Federation; 2021. 1–135 p. Available from: www.diabetesatlas.org
Hingorani A, Lamuraglia GM, Henke P, Meissner MH, Loretz L, Zinszer KM, et al. The management of diabetic foot: a clinical practice guideline by the society for vascular surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of Vascular Surgery. 2016;63(2):3S-21S. DOI: 10.1016/j.jvs.2015.10.003
Nugroho NT, Nasution MR. Diabetic foot ulcer on coronavirus patient. Journal of Indonesian Society for Vascular and Endovascular Surgery. 2024;3(1):3–7. DOI: 10.36864/jinasvs.2024.1.001
Ha JH, Jin H, Park JU. Association between socioeconomic position and diabetic foot ulcer outcomes: a population-based cohort study in South Korea. BMC Public Health. 2021;21(1):1–9. DOI: 10.1186/s12889-021-11406-3
Brown AF, Ettner SL, Piette J, Weinberger M, Gregg E, Shapiro MF, et al. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiologic Reviews. 2004;26:63–77. DOI: 10.1093/epirev/mxh002
UNICEF, UNDP, Prospera, SMERU. Analysis of the social and economic impacts of COVID-19 on households and strategic policy recommendations for Indonesia [Internet]. United Nations Children’s Fund (UNICEF). 2021. 1–65 p. Available from: https://www.unicef.org/indonesia/media/9501/file/AnalysisoftheSocialandEconomicImpactsofCOVID-19onHouseholdandStrategicPolicyRecommendationsforIndonesia.pdf
Yunir E, Tarigan TJE, Iswati E, Sarumpaet A, Christabel EV, Widiyanti D, et al. Characteristics of diabetic foot ulcer patients pre- and during COVID-19 pandemic: lessons learnt from a national referral hospital in Indonesia. Journal of Primary Care and Community Health. 2022;13(71):1–8. DOI: 10.1177/21501319221089767
UNICEF, UNDP, Prospera, SMERU Research Institute. The social and economic impact of COVID-19 on households in Indonesia: a second round of surveys in 2022. 2022;1–134. Available from: https://www.unicef.org/indonesia/reports/social-and-economic-impact-covid-19-households-indonesia
Indonesian Ministry of Health. National Health Research Report 2018. Balitbangkes. Jakarta; 2019. 1–628 p.
Matilde Monteiro-Soares& João Vasco Santos. IDF Diabetes Atlas report on diabetes foot-related complications. Dianna J Magliano, Edward J Boyko, Irini Genitsaridi, Lorenzo Piemonte, Phil Riley PS, editor. IDF. International Diabetes Federation; 2022. Available from: https://diabetesatlas.org/idfawp/resource-files/2022/12/IDF-Diabetic-Foot-Report.pdf
Soewondo P, Ferrario A, Tahapary DL. Challenges in diabetes management in Indonesia: a literature review. Global Health. 2013;9(1):1–17. DOI: 10.1186/1744-8603-9-63
Kshanti IA, Epriliawati M, Mokoagow MI, Nasarudin J, Magfira N. The Impact of COVID-19 lockdown on diabetes complication and diabetes management in people With diabetes in Indonesia. Journal of Primary Care and Community Health. 2021;12. DOI: 10.1177/21501327211044888
WHO. Health systems : improving performance [Internet]. World Health Organization, editor. The world health report 2000. Geneva, Switzerland: World Health Organization 2000; 2000. 1–206 p. Available from: http://www.who.int/whr/2000/en/whr00_en.pdf
Wiseman V, Thabrany H, Asante A, Haemmerli M, Kosen S, Gilson L, et al. An evaluation of health systems equity in Indonesia: Study protocol. International Journal for Equity in Health. 2018;17(1):1–9. DOI: 10.1186/s12939-018-0822-0
Kristina SA, Endarti D, Andayani TM, Widayanti AW. Direct and indirect cost of diabetes mellitus in Indonesia: a prevalence based study with human capital approach. International Journal of Pharmaceutical Research. 2020;13(01). DOI: 10.31838/ijpr/2021.13.01.331
Pratiwi AB, Setiyaningsih H, Kok MO, Hoekstra T, Mukti AG, Pisani E. Is Indonesia achieving universal health coverage? Secondary analysis of national data on insurance coverage, health spending and service availability. BMJ Open. 2021;11(10). DOI: 10.1136/bmjopen-2021-050565
Asante A, Cheng Q, Susilo D, Satrya A, Haemmerli M, Fattah RA, et al. The benefits and burden of health financing in Indonesia: analyses of nationally representative cross-sectional data. Lancet Global Health. 2023;11(5):e770–80. DOI: 10.1016/S2214-109X(23)00064-5
Maulana N, Soewondo P, Adani N, Limasalle P, Pattnaik A. How jaminan kesehatan nasional (JKN) coverage influences out-of-pocket (OOP) payments by vulnerable populations in Indonesia. PLOS Global Public Health. 2022;2(7):e0000203. DOI: 10.1371/journal.pgph.0000203
Kemenkes RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 3 Tahun 2023 Tentang Standar Tarif Pelayanan Kesehatan Dalam Penyelenggaraan Program Jaminan Kesehatan. Indonesia; 2023 p. 1–721.
Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 16. Diabetes care in the hospital: standards of care in diabetes—2023. Diabetes Care. 2023;46(January):S267–78. DOI: 10.2337/dc23-S016
PERKENI. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2021. Juli 2021. PERKENI, editor. Jakarta: PB. PERKENI; 2021. 1–119 p.
Yunir E, Tahapary DL, Tarigan TJE, Harbuwono DS, Oktavianda YD, Kristanti M, et al. Non-vascular contributing factors of diabetic foot ulcer severity in national referral hospital of Indonesia. Journal of Diabetes and Metabolic Disorders . 2021;20(1):805–13. DOI: 10.1007/s40200-021-00827-x
Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clinical Nutrition. 2017;36(1):49–64. DOI: 10.1016/j.clnu.2016.09.004
Yoon JL, Cho JJ, Park KM, Noh HM, Park YS. Diagnostic performance of body mass index using the western pacific regional office of world health organization reference standards for body fat percentage. Journal of Korean Medical Science. 2015;30(2):162–6. DOI: 10.3346/jkms.2015.30.2.162
Senneville É, Albalawi Z, Asten SA Van, Abbas ZG, Allison G, Aragón-sánchez J, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF / IDSA 2023). Clinical Infectious Diseases. 2023;1–23. DOI: 10.1093/cid/ciad527/7287196
Pratama V. Analisis efektivitas biaya antara ampisilin/sulbaktam dan non-ampisilin/sulbaktam pada pasien infeksi kaki diabetik rawat inap di RSUPN DR. Cipto Mangunkusumo. [Thesis]. Depok: Universitas Indonesia; 2022. 183 p.
Yunir E, Hidayah CD, Harimurti K, Kshanti IAM. Three years survival and factor predicting amputation or mortality in patients with high risk for diabetic foot ulcer in Fatmawati general hospital, Jakarta. Journal of Primary Care and Community Health. 2022;13(71):1–7. DOI: 10.1177/21501319211063707
Schaper NC, Dryden M, Kujath P, Nathwani D, Arvis P, Reimnitz P, et al. Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: Results of the RELIEF study. Infection. 2013;41(1):175–86. DOI: 10.1007/s15010-012-0367-x
Pemayun TGD, Naibaho RM. Clinical profile and outcome of diabetic foot ulcer, a view from tertiary care hospital in Semarang, Indonesia. Diabetic Foot and Ankle. 2017;8(1):1–8. DOI: 10.1080/2000625X.2017.1312974
Jiskrova GK, Bobák M, Pikhart H, Ksinan AJ. Job loss and lower healthcare utilisation due to COVID-19 among older adults across 27 European countries. Journal of Epidemiology and Community Health. 2021;34(0):1–6. DOI: 10.1136/jech-2021-216715
Pride L, Kabeil M, Alabi O, Minc SD, Fakorede FA, Ochoa LN, et al. A review of disparities in peripheral artery disease and diabetes–related amputations during the COVID-19 pandemic. Seminars in Vascular Surgery. 2023;36(January):90–9. DOI: 10.1053/j.semvascsurg.2022.12.002
Sucahya PK. Barriers to COVID-19 RT-PCR testing in Indonesia: a health policy perspective. Journal of Indonesian Health Policy and Administration. 2020;5(2):36–42. DOI: 10.7454/ihpa.v5i2.3888
International Working Group on the Diabetic Foot. Covid-19 and diabetic foot disease. 2019 [cited 2024 Jun 22]. p. 1–7. Available from: https://iwgdfguidelines.org/covid-19/
Indrayana S, Guo SE, Lin CL, Fang SY. Illness perception as a predictor of foot care behavior among people with type 2 diabetes mellitus in Indonesia. Journal of Transcultural Nursing. 2019;30(1):17–25. DOI: 10.1177/1043659618772347
Aviatin M, Sauriasari R, Yunir E, Risni HW. Evaluation of the use of antimicrobial therapy for treating diabetic foot infections in an Indonesia referral hospital: a retrospective cohort study. Infection and Chemotherapy. 2023;55(1):80–9. DOI: 10.3947/ic.2022.0084
Ndosi M, Wright-Hughes A, Brown S, Backhouse M, Lipsky BA, Bhogal M, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabetic Medicine. 2018;35(1):78–88. DOI: 10.1111/dme.13537
Vanherwegen AS, Lauwers P, Lavens A, Doggen K, Dirinck E, Lusendi FM, et al. Sex differences in diabetic foot ulcer severity and outcome in Belgium. PLoS One. 2023;18(2 February):1–13. DOI: 10.1371/journal.pone.0281886
Copyright (c) 2025 Jurnal Kefarmasian Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
